<DOC>
	<DOCNO>NCT01914380</DOCNO>
	<brief_summary>The study aim investigate effectiveness Eylea patient wet age-related macular degeneration routine clinical practice Germany . The study purely observational , data routine treatment collect . The treatment treatment condition solely discretion treat physician .</brief_summary>
	<brief_title>Investigating Effectiveness Eylea Patients With Wet Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Patients wet wAMD treat Eylea ( accordance local Summary Product Characteristics , SPC ) . Written informed consent . Exclusion criterion list local SPC . Scar , fibrosis , atrophy involve center fovea study eye . Any concomitant therapy another agent treat wet AMD study eye .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Wet age-related macular degeneration</keyword>
	<keyword>Anti-VEGF-Therapy</keyword>
	<keyword>Observational study</keyword>
</DOC>